ATOM Coalition
@ATOM_Coalition
Followers
420
Following
353
Media
39
Statuses
154
The Access to Oncology Medicines Coalition is a global initiative led by UICC that aims to increase access to #cancermedicines in LLMICs. #ATOMCoalition
Joined May 2022
RT @uicc: š @ATOM_Coalition has released its first Health Financing Case Studies on Georgia, Kenya, the Philippines & Zambia ā offering insā¦.
0
3
0
Weāre proud to see ATOM Coalition partner @MedsPatentPool spotlighted on @WIPOās #MissionImagination podcast! šĀ Watch the episode and find out more about how weāre partnering to address barriers to medicines access for all:
uicc.org
The Access to Oncology Medicines (ATOM) Coalition ambition's is "to reduce suffering and deaths caused by cancer in low- and lower-middle income countries through improved access to and use of...
0
2
3
Yesterday, partners gathered at the @uicc offices in Geneva for the annual @ATOM_Coalition meeting, marking the Coalitionās third anniversary. Held during #WHA78, the event was a moment to reflect on progress and look ahead in expanding access to essential #cancermedicines.
0
1
3
A new @TheLancetOncol commentary highlights how the @uicc-led @ATOM_Coalition is breaking barriers to cancer treatment in low- and middle-income countriesāthrough licensing, donations, and stronger supply chains.
uicc.org
Experts from UICC outline sustainable strategies being developed by the ATOM Coalition to tackle critical barriers in cancer treatment access across low- and middle-income countries, including...
0
0
2
UICC welcomes the ACT for Children initiative with @Servier, @IDAFoundation, @WorldChildCancer, @ChildCancerIntl & @ResonanceCRO. With the UICC-led ATOM Coalition, USD 2.3M in medicines reached cancer centres in Asia & Central America.
uicc.org
UICC welcomes the launch of the Access Cancer Treatment (ACT) for Children initiative, which aims to address the disparities in childhood cancer care in low- and middle-income countries (LMICs).Ā
0
0
2
Access to medicines for #NCDs, including #cancer, is a challengeābut progress is within reach. Join the @uicc-led @ATOM_Coalition on 23 Jan at 14:00 CET to explore 5 key strategies for improving access. @ncdalliance @UNIGEnews .
0
2
6
The FDA approval of @heteroofficial's generic #nilotinib is a key step in improving access to #cancer treatments in LMICs. It highlights the @uicc-led ATOM Coalition's success in leveraging partnerships to save lives. @MPP @IDA_Foundation @themaxfndn.
š Exciting News! š .š£MPP, @ATOM_Coalition, @IDA_Foundation, and @themaxfndn announce @US_FDA approval for @heteroofficial's generic #nilotinib for chronic myeloid #leukaemia (#CML). šThis milestone enhances access to #cancer treatment options in low- and middle-income
0
1
4
Ulaanbaatar, Mongolia: ATOM Coalition hosted a 3-day workshop to advance access to quality cancer medicines. As the year ends, we look ahead to 2025 with actionable solutions to improve cancer care, shaped by global partners and country collaborations.
uicc.org
This week, the UICC-led ATOM Coalition hosted a three-day workshop (26ā28 November 2024) in Ulaanbaatar, Mongolia.Ā
0
1
2
RT @MedsPatentPool: š Exciting News! š .š£MPP, @ATOM_Coalition, @IDA_Foundation, and @themaxfndn announce @US_FDA approval for @heteroofficiā¦.
0
4
0
The ATOM Coalition is seeking an expert to lead its country support programme. This 12-month consultancy will help drive access to essential cancer medicines in El Salvador, Mongolia, Zambia, Uganda, and Honduras. Apply now!.
0
0
1
A big thank you to everyone who visited the ATOM Coalition booth! Weāre excited for continued discussions and future collaborations.
It was an inspiring #WorldCancerCongress in Geneva! Grateful for the knowledge shared, connections made, and commitment to advancing cancer control. Thank you to all who made it a success. Letās continue working together to drive meaningful action against cancer. Until next time!
0
4
9
Looking forward to #WCC2024 in Geneva. We're eager to see our partners take the stage during their sessions. Don't forget to visit the ATOM Coalition booth in the Global Village. Together, we can make Access to Oncology Medicines a reality. Join us there:
0
0
3
Over 80 UICC members and partners joined our Virtual Dialogue on ATOM Medicines Access Pathways, in collaboration with @IDA_Foundation. It addressed global medicine accessibility, regulatory pathways and ATOM-secured medicines. Watch the sessions:
uicc.org
TheĀ ATOM CoalitionĀ addresses key issues that impact the ability of countries and patients to access life-saving cancer diagnostics and medicines.
0
0
3
RT @ASCO: At the #WhiteHouseAfricaCancerCareForum, Dr. @jrgralow discussed several of ASCOās global efforts in support of research, professā¦.
0
10
0
The White House African Cancer Forum on July 15 focused on US efforts to build capacity in cancer control in Africa. UICC Board Member @m_mutebi highlighted national cancer programs and strategies reducing Africa's cancer burden. Missed it? Watch here.
0
1
8
ATOM Coalition roundtableās at #ASCO24 discussed ways to boost access to immune-oncology medicines in resource-limited settings. This means tackling barriers in regulatory affairs, supply chains, pathology, diagnostics, and clinical use.
0
5
10
RT @uicc: The UICC-led @ATOM_Coalition marks its second anniversary. š. The Coalition has made significant strides in expanding access to eā¦.
0
4
0
We are excited to see our partner @bmsnews launch their ASPIRE strategy, a 10-year commitment to improve access to life-saving treatments and #cancer medicines in low- and middle-income countries. šš.
#MEDIA: Today we announced ASPIRE, a 10-year strategy to advance equitable access to our innovative medicines in low- and middle-income countries, including collaborating with @ATOM_Coalition led by the @uicc to expand access to immuno-oncology therapy.
0
2
8
It was a pleasure to welcome the Private Sector Council of the ATOM Coalition. Building on shared achievements, we explored new opportunities and next steps. Together, we're advancing access to vital oncology medicines, ensuring every patient receives the care they need.
0
3
10